Meningitis B outbreak

Meningitis B Outbreak – Practice Information Script

Current Situation

There is an ongoing meningococcal disease outbreak in Kent, primarily linked to young adults and university settings. The strain involved is Meningitis B (MenB), and cases have risen to around 20 confirmed or suspected so far. This outbreak is currently considered unprecedented due to the speed at which cases have appeared.

Risk to the General Public

At present, there is no new advice for the wider public and the overall risk outside the outbreak area remains low. The outbreak is centred in Kent, especially university halls and a specific nightclub exposure. There is no evidence of broader community spread outside these settings.

Vaccination Status & Eligibility

No new national guidance has been issued recommending the MenB vaccine for the general population. Most teenagers and young adults have not received MenB as infants because the programme began in 2015. Secondary-school-aged children do have MenACWY vaccination protection. Private MenB vaccination is available but currently in high demand with some local shortages.

Who Is Currently Being Offered Vaccination or Antibiotics?

UKHSA is providing targeted antibiotics and MenB vaccination specifically to university students in Kent and those who attended Club Chemistry (5–7 March). No national catch‑up programme has been announced.

Symptoms to Watch For

Seek urgent medical help if symptoms occur: fever, severe headache, neck stiffness, vomiting, cold hands/feet, drowsiness/confusion, or a rash that does not fade under pressure.

What Patients Should Do Now

Check that routine vaccinations, especially MenACWY, are up to date. Those in high‑risk exposure groups will be contacted by UKHSA. There is no recommendation for the general public to seek MenB vaccination unless they are in affected contact groups.

General Practice Statement

We understand the concern caused by current news reports. We are following official UKHSA and NHS guidance, and we will update our advice immediately if national recommendations change.